Silexion Therapeutics Corp (SLXN)
NASDAQ: SLXN · Real-Time Price · USD
1.662
-0.068 (-3.91%)
Mar 3, 2026, 4:00 PM EST - Market closed
Silexion Therapeutics Market Cap
Silexion Therapeutics has a market cap or net worth of $5.2 million as of March 4, 2026. Its market cap has decreased by -42.81% in one year.
Market Cap
5.20M
Enterprise Value
-2.02M
1-Year Change
-42.81%
Ranking
Category
Stock Price
$1.66
Market Cap Chart
Since April 7, 2021, Silexion Therapeutics's market cap has decreased from $148.55M to $5.20M, a decrease of -96.50%. That is a compound annual growth rate of -49.50%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 5.20M | -13.42% |
| Dec 31, 2025 | 6.00M | 86.31% |
| Dec 31, 2024 | 3.22M | -92.33% |
| Dec 21, 2023 | 41.99M | -71.93% |
| Dec 30, 2022 | 149.59M | 4.03% |
| Dec 31, 2021 | 143.80M | -3.20% |
| Apr 7, 2021 | 148.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Revelation Biosciences | 5.84M |
| Processa Pharmaceuticals | 5.76M |
| Calidi Biotherapeutics | 5.57M |
| Xenetic Biosciences | 5.34M |
| Quince Therapeutics | 5.30M |
| Cyclerion Therapeutics | 5.14M |
| Silo Pharma | 5.10M |
| VivoSim Labs | 5.01M |